CRISPR Therapeutics, Zugocabtagene Geleucel, Zugo-cel, CAR T Cell Therapy, CRISPR Cas9, Gene Editing, CD19, Autoimmune Disease,

ZUG, Switzerland and BOSTON — October 2, 2026 CRISPR Therapeutics announced that new Phase 1 clinical data for zugocabtagene...